CPAY vs LRCX
Corpay vs Lam Research — AI-powered side-by-side comparison
| Metric | CPAY | LRCX |
|---|
| AI Score |
71
|
64
|
| Price |
$393.20
|
$311.31
|
| P/E Ratio |
23.60×
|
53.77×
|
| ROE |
27.5%
|
58.3%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
73.3%
|
50.5%
|
| Debt / Equity |
2.35×
|
0.30×
|
| Dividend Yield |
0.0%
|
0.3%
|
| RSI (14) |
61.8
|
53.1
|
| Beta |
0.881
|
1.805
|
| Expected Upside |
+1.9%
|
+40.8%
|
AI Committee View
Current Innellis committee reasoning for CPAY versus LRCX.
CPAY leads by 7 points.
CPAY scores 71/100 (Buy) versus LRCX at 64/100 (Buy).
CPAY Committee View
100% agreement
4 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is 4 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Risk/reward is unfavorable: 14.7% downside vs 1.9% upside.
LRCX Committee View
50% agreement
6 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- ROE of 67.0% shows genuine earnings power backing the valuation — Value
- Revenue growing 26.0% YoY -- genuine top-line momentum — Growth
- EPS growing 38.6% YoY — Growth
Bear Case
- P/E of 53.6 is expensive by classic value standards — Value
- Price-to-book of 41.2x prices in significant intangible value — Value
- Bollinger bandwidth of 28.0% signals elevated volatility — Risk